DR. EVY GOOSSENS
ActiveSummary
DR. EVY GOOSSENS has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €86k and a net result of €24k. Equity is growing by ~38.2% per year across the filed fiscal years. Its solvency ranks better than 92% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth52=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8k at 30 days acceptable
Liquidity ample (current ratio 21.46 against 30.99 in 2024; short-term debt: 4.7% and cash: 85.8% of total assets), and 4.7% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
95.3%
Return on assets
26.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-03-2026, 133 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
133 d early
2024
129 d early
2023
48 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€86k▲ 38.6%
2024 · €62k
2023: €38k
2024: €62k
2023 → 2025
Total assets
€90k▲ 40.7%
2024 · €64k
2023: €42k
2024: €64k
2023 → 2025
Net result
€24k▼ 5.1%
2024 · €25k
2023: €36k
2024: €25k
2023 → 2025
Working capital
€86k▲ 38.6%
2024 · €62k
2023: €38k
2024: €62k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€38k-€62k▲ 61.0%€86k▲ 38.6%
Operating result€47k-€33k▼ 30.6%€31k▼ 5.3%
Net result€36k-€25k▼ 31.1%€24k▼ 5.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 5% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €90k
Equity
€86k ▲ 38.6%
Debt
€4k ▲ 103%
Debt's share of the balance-sheet total rises from 3.2% to 4.7%. Equity and debt are higher.
Key figures and ratios
Current ratio
21.46▼
2024 · 30.99
Debt to equity
0.05▲
2024 · 0.03
ROE
27.9%▼
2024 · 40.7%
ROA
26.6%▼
2024 · 39.4%
Debt ≤ 1 year
€4k▲
2024 · €2k
Income taxes
€6k▼
2024 · €7k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 32 lines
Balance sheet
Code20242025
Assets
Total assets20/58€64k€90k▲
Current assets29/58€64k€90k▲
Amounts receivable within one year40/41€4k€2k▼
Other amounts receivable41€4k€2k▼
Cash at bank and in hand54/58€50k€77k▲
Deferred charges and accrued income490/1€9k€11k▲
Equity and liabilities
Total equity and liabilities10/49€64k€90k▲
Equity10/15€62k€86k▲
Contributions10/11€4k€4k=
Reserves13€58k€82k▲
Distributable reserves133€58k€82k▲
Amounts payable17/49€2k€4k▲
Amounts payable within one year42/48€2k€4k▲
Trade debts44€52€676▲
Suppliers440/4€52€676▲
Other amounts payable47/48€2k€4k▲
Income statement
Code20242025
Other operating charges640/8€351€790▲
Gross operating margin9900€33k€32k▼
Operating profit (loss)9901€33k€31k▼
Financial income75/76B€0€0▼
Recurring financial income75€0€0▼
Financial charges65/66B€747€634▼
Recurring financial charges65€747€634▼
Profit (loss) for the period before taxes9903€32k€30k▼
Income taxes67/77€7k€6k▼
Profit (loss) for the period9904€25k€24k▼
Profit (loss) for the period to be appropriated9905€25k€24k▼
Appropriation of the result
Profit (loss) to be appropriated9906€25k€24k▼
Transfer to equity691/2€23k€24k▲
To other reserves6921€23k€24k▲
Profit to be distributed694/7€2k-
Return on contributions (dividend)694€2k-
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €24k ▼5.1%
Net result drops to €24k, the lowest in the series.
24-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity doublescurrent ratio 30.99
Current ratio from 13.06 to 30.99; short-term debt falls from €3k to €2k.
13-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kalmthout · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Van Dammedreef (Heide) 82920 KalmthoutGround area
2,631 m²
Building footprint
313 m²
Volume, LiDAR
1,926 m³
2 parcels, Flanders · tallest building 9.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. EVY GOOSSENS
since 20222.336.172.051
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11662E0594/00A019 | Flanders | 1,925 m² | 1 · 208 m² | 9.1 m · 2 fl. |
| 12404G0509/00L000 | Flanders | 706 m² | 1 · 104 m² | 9.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Tom Lambrechts Huisarts
BE 0673.997.372
Arendonk · Eq €85,632
DOCTEUR QUENTIN GRZESINSKI
BE 0800.451.126
Liège · Eq €85,617
MSRI
BE 1014.085.312
Genk · Eq €85,610
DOKTER MARLIES DEGROOTE
BE 0781.577.993
Kuurne · Eq €85,739
Dr.Linde Germijns
BE 0792.828.807
Zoersel · Eq €85,572
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,159 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-09-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.